Richard S. Lindahl - 29 Feb 2024 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Signature
/s/ Jennifer Lynne Fox, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
29 Feb 2024
Net transactions value
-$31,508
Form type
4
Filing time
04 Mar 2024, 18:42:50 UTC
Previous filing
27 Feb 2024
Next filing
15 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability $29,190 -9,037 -5.4% $3.23 159,426 29 Feb 2024 Direct F1
transaction EBS Common Stock Tax liability $2,319 -684 -0.43% $3.39 158,742 01 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes.